Follow Newser on Twitter   Friend Newser on Facebook
Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Big Pharma Faces Big Plunge

Profits will drop as patents expire, and chemical-based therapies are eclipsed by biotech

By Peter Fearon,  Newser Staff

Posted Dec 6, 2007 4:50 AM CST

(Newser) – Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half...   Read full story »

COMMENTS
You need to Log in to Newser to comment. Don't have an account yet? Sign up now!
There are no comments
A snapshot of the day's best news stories.
 

More Newser Stories

Disgraced Doctors Land at Big Pharma

Novartis Acquires Plavix Rival

Pfizer to Can 800 Researchers

Big Pharma Seeks Big Profits in Developing Nations

Deal Delays Generic Lipitor Until 2011


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   Geek Sugar   |   Business Insider   |   HuffPost Entertainment